Katabi Maha

Track

Insider profile

Performance

Overall performance
3.3
Performance over holding periods
3.3
30 days 90 days 120 days
Average return 3% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
6 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Katabi Maha's trades of Vera Therapeutics, Inc.'s stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
US RayzeBio Inc (RYZB)
Transaction date
Purchase
Price
18.00
Quantity 236,111 +24.3%
Value US$4,249,998
US RayzeBio Inc (RYZB)
Transaction date
Purchase
Price
18.00
Quantity 236,111 +24.3%
Value US$4,249,998
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-03-25 2024-03-25
S Sale
27,858 -38.9%
22.22
US$2,883,068 		27,858 -38.9% 22.22 US$2,883,068
2024-03-25 2024-03-22
S Sale
95,465 -38.4%
210.82
US$3,547,540 		95,465 -38.4% 210.82 US$3,547,540
2024-03-25 2024-03-21
S Sale
56,700 +16.9%
246.71
US$3,133,883 		56,700 +16.9% 246.71 US$3,133,883
2024-03-25 2024-03-21
S Sale
12,617 -0.4%
45.52
US$574,326 		12,617 -0.4% 45.52 US$574,326
2024-03-25 2024-03-21
S Sale
21,918 -0.6%
44.00
US$964,392 		21,918 -0.6% 44.00 US$964,392
2024-03-25 2024-03-21
S Sale
32,756 -0.9%
43.00
US$1,408,508 		32,756 -0.9% 43.00 US$1,408,508
2024-03-21 2024-03-21
PrS Proposed sale
850,000
45.33
US$38,530,500 		850,000 45.33 US$38,530,500
2024-02-01 2024-01-30
B Purchase
161,290 +4.7%
31.00
US$4,999,990 		161,290 +4.7% 31.00 US$4,999,990
2023-09-21 2023-09-19
US RayzeBio Inc (RYZB)
B Purchase
236,111 +24.3%
18.00
US$4,249,998 		236,111 +24.3% 18.00 US$4,249,998
2023-09-21 2023-09-19
US RayzeBio Inc (RYZB)
B Purchase
236,111 +24.3%
18.00
US$4,249,998 		236,111 +24.3% 18.00 US$4,249,998